Financials
- Market Capitalization 2.24 M
- Employee 2
- Founded 2013
- CEO N/A
- Website www.matinasbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG005WX2XG8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.25
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 5075 | OGEN Oragenics Inc. Common Stock | 0.57 USD | -3.39% | -1.72% | -8.06% | -10.02% | 2.57 M USD | ||
| 5083 | CLDI Calidi Biotherapeutics, Inc. Common Stock | 0.12 USD | -7.69% | -14.29% | -25.00% | -84.12% | 2.32 M USD | ||
| 5090 | PHGE BiomX Inc. COmmon Stock | 0.22 USD | 0.00% | -15.38% | -60.71% | -95.90% | 2.23 M USD | ||
| 5092 | VRAX Virax Biolabs Group Limited - Ordinary Shares | 3.74 USD | -8.11% | +23.84% | +2237.50% | +325.00% | 2.17 M USD |